Ophthalmic Solutions
Showing 2426 - 2450 of 2,869
Eyes Dry Chronic Trial in Fort Worth (ESBA105 ophthalmic solution, ESBA105 vehicle)
Completed
- Eyes Dry Chronic
- ESBA105 ophthalmic solution
- ESBA105 vehicle
-
Fort Worth, TexasContact Alcon Call Center for Trial Locations
Apr 18, 2013
Glaucoma Trial in Fort Worth (Brinzolamide 1% and timolol 0.5% fixed combination eye drops)
Completed
- Glaucoma
- Brinzolamide 1% and timolol 0.5% fixed combination eye drops
-
Fort Worth, TexasContact Alcon Call Center for Trial Locations
Apr 25, 2013
Cataract, Surgery, Eye Pain Trial in Shanghai (First eye (FE), Second eye (SE), Steroids eye drops)
Unknown status
- Cataract
- +2 more
- First eye (FE)
- +2 more
-
Shanghai, Shanghai, ChinaEye and ENT Hospital of Fudan University
Apr 4, 2013
Bioavailability Study on Healthy Volunteers Trial in Rennes, Rueil Malmaison (Certolizumab pegol)
Completed
- Bioavailability Study on Healthy Volunteers
- Certolizumab pegol
-
Rennes, France
- +1 more
Sep 6, 2013
Dry Eye Syndrome Trial in Vienna (Chitosan- N- Acetylcysteine eye drops, Placebo)
Completed
- Dry Eye Syndrome
- Chitosan- N- Acetylcysteine eye drops
- Placebo
-
Vienna, AustriaMedical University of Vienna, Department of Clinical Pharmacolog
Apr 4, 2013
Laser In Situ Keratomileusis Trial in Overland Park (Cyclosporine 0.010% eye drops, Cyclosporine 0.005% eye drops, Placebo
Completed
- Laser In Situ Keratomileusis
- Cyclosporine 0.010% eye drops
- +2 more
-
Overland Park, Kansas(unnamed)
Jul 9, 2013
Diabetes, Obesity Trial in Nashville (Lifestyle counseling)
Completed
- Diabetes
- Obesity
- Lifestyle counseling
-
Nashville, TennesseeColeman Community Recreation Center
Dec 17, 2013
Allergic Conjunctivitis Trial in Irvine (Bepreve (bepotastine besilate ophthalmic solution) 1.5%, comparator, Bepotastine
Completed
- Allergic Conjunctivitis
- Bepreve (bepotastine besilate ophthalmic solution) 1.5%
- +2 more
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Feb 4, 2013
Pterygium, Bevacizumab, VEGF Trial in Pathumwan (bevacizumab eye drop 0.05%, normal saline 0.9%)
Completed
- Pterygium
- +3 more
- bevacizumab eye drop 0.05%
- normal saline 0.9%
-
Pathumwan, Bangkok, ThailandFaculty of medicine, Chulalongkorn university
Apr 6, 2013
Corneal Infiltrates Trial in Fort Worth (Moxifloxacin/dexamethasone phosphate ophthalmic solution, Moxifloxacin ophthalmic
Terminated
- Corneal Infiltrates
- Moxifloxacin/dexamethasone phosphate ophthalmic solution
- +2 more
-
Fort Worth, TexasContact Alcon Call Center at 1-888-451-3937
Dec 3, 2012
Open-Angle Glaucoma, Ocular Hypertension Trial in Fort Worth (AL-37807 ophthalmic suspension, 0.1%, Timolol gel forming
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- AL-37807 ophthalmic suspension, 0.1%
- +3 more
-
Fort Worth, TexasContact Alcon Call Center at 1-888-451-3937
Dec 3, 2012
Alzheimer Trial in Caen (Memory assessment, Brain imaging examination MRI)
Unknown status
- Alzheimer Disease
- Memory assessment
- Brain imaging examination MRI
-
Caen, FranceGIP Cyceron
Apr 8, 2014
Persistent Corneal Epithelial Defect Trial in Osaka (DE-105 ophthalmic solution, Placebo ophthalmic solution)
Completed
- Persistent Corneal Epithelial Defect
- DE-105 ophthalmic solution
- Placebo ophthalmic solution
-
Osaka, JapanSanten study sites
Nov 21, 2012
Dry Eye Trial in Shanghai, Singapore (diquafosol ophthalmic solution, 0.1% sodium hyaluronate ophthalmic solution.)
Completed
- Dry Eye
- diquafosol ophthalmic solution
- 0.1% sodium hyaluronate ophthalmic solution.
-
Shanghai, China
- +1 more
Nov 11, 2012
Type I Allergy Trial in Darmstadt (Skin Prick Test)
Completed
- Type I Allergy
- Skin Prick Test
-
Darmstadt, Hessen, GermanyKlinikum Darmstadt
Nov 7, 2013
Pain, Retinopathy of Prematurity Trial in Philadelphia (Proparacaine Hydrochloride Ophthalmic Solution)
Terminated
- Pain
- Retinopathy of Prematurity
- Proparacaine Hydrochloride Ophthalmic Solution
-
Philadelphia, PennsylvaniaPennsylvania Hospital NICU
Feb 15, 2013
Angle Closure (Glaucoma) in Caucasians
Unknown status
- Glaucoma, Angle-Closure
-
Maastricht, NetherlandsUniversity Eye Clinic Maastricht
Feb 3, 2014
Substance Abuse Treatment for Adults Trial (ASI-MV Solutions)
Completed
- Substance Abuse Treatment for Adults
- ASI-MV Solutions
- (no location specified)
Sep 20, 2013
Brittle Nails Trial in New York (Restasis (cyclosporine ophthalmic emulsion) 0.05%, Refresh® Dry Eye therapy)
Completed
- Brittle Nails
- Restasis (cyclosporine ophthalmic emulsion) 0.05%
- Refresh® Dry Eye therapy
-
New York, New YorkColumbia University Medical Center Department of Dermatology
Jul 17, 2013
Glaucoma, Open-Angle, Ocular Hypertension Trial in Rogers, Calgary (bimatoprost ophthalmic solution 0.01%, travoprost ophthalmic
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- bimatoprost ophthalmic solution 0.01%
- +2 more
-
Rogers, Arkansas
- +1 more
Oct 8, 2012
Arthroplasty, Replacement, Hip Trial in Baltimore (CHG 2% w/v and IPA 70% v/v, Iodophor 0.7% and IPA 74% w/w)
Completed
- Arthroplasty, Replacement, Hip
- CHG 2% w/v and IPA 70% v/v
- Iodophor 0.7% and IPA 74% w/w
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Jun 5, 2013
Glaucoma Trial in Fort Worth (Brinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspension, Brimonidine 20 mg/ml/Timolol 5 mg/ml
Completed
- Glaucoma
- Brinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspension
- Brimonidine 20 mg/ml/Timolol 5 mg/ml eye drops solution
-
Fort Worth, TexasContact Alcon Call Center at 1-888-451-3937 For Trial Locations
Mar 20, 2013